You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 14, 2024

Investigational Drug Information for Tradipitant


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Tradipitant?

Tradipitant is an investigational drug.

There have been 13 clinical trials for Tradipitant. The most recent clinical trial was a Phase 3 trial, which was initiated on October 21st 2019.

The most common disease conditions in clinical trials are Motion Sickness, Eczema, and Dermatitis, Atopic. The leading clinical trial sponsors are Vanda Pharmaceuticals, Mayo Clinic, and Cross Research S.A.

There are fifteen US patents protecting this investigational drug and one hundred and sixty-four international patents.

Recent Clinical Trials for Tradipitant
TitleSponsorPhase
Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion SicknessVanda PharmaceuticalsPhase 3
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion SicknessVanda PharmaceuticalsPhase 3
Pharmacodynamics, Pharmacogenetics, Clinical Efficacy and Safety of Tradipitant for Functional DyspepsiaMayo ClinicPhase 2

See all Tradipitant clinical trials

Clinical Trial Summary for Tradipitant

Top disease conditions for Tradipitant
Top clinical trial sponsors for Tradipitant

See all Tradipitant clinical trials

US Patents for Tradipitant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tradipitant ⤷  Sign Up Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone ELI LILLY AND COMPANY (Indianapolis, IN) ⤷  Sign Up
Tradipitant ⤷  Sign Up Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign Up
Tradipitant ⤷  Sign Up Process development of a pyridine-containing NK-1 receptor antagonist ELI LILLY AND COMPANY (Indianapolis, IN) ⤷  Sign Up
Tradipitant ⤷  Sign Up Method of treatment with tradipitant VANDA PHARMACEUTICALS INC. (Washington, DC) ⤷  Sign Up
Tradipitant ⤷  Sign Up ⤷  Sign Up
Tradipitant ⤷  Sign Up Method of treatment with tradipitant VANDA PHARMACEUTICALS INC. (Washington, DC) ⤷  Sign Up
Tradipitant ⤷  Sign Up Use of tradipitant in motion sickness Vanda Pharmaceuticals Inc. (Washington, DC) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tradipitant

Drugname Country Document Number Estimated Expiration Related US Patent
Tradipitant Australia AU2007337255 2026-12-20 ⤷  Sign Up
Tradipitant Brazil BRPI0721069 2026-12-20 ⤷  Sign Up
Tradipitant Canada CA2671770 2026-12-20 ⤷  Sign Up
Tradipitant China CN101568523 2026-12-20 ⤷  Sign Up
Tradipitant Cyprus CY1115270 2026-12-20 ⤷  Sign Up
Tradipitant Denmark DK2121610 2026-12-20 ⤷  Sign Up
Tradipitant Eurasian Patent Organization EA200970604 2026-12-20 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.